Cell-cycle transitions are regulated by the periodic activities of a family of closely related enzymes, the cyclin-dependent kinases. In yeast, this is accomplished by a single cyclindependent kinase, whereas mammalian cells have evolved multiple cyclin-dependent kinases, presumably to accommodate the increased need for cell-cycle control required by complex organisms. Monomeric cyclin-dependent kinases are catalytically inactive, and are activated by regulatory subunits termed cyclins. Cyclins not only activate but also direct their partner cyclin-dependent kinases to substrates, the phosphorylation of which leads to cell-cycle progression.
was stimulated. The interest of Hosoya et al. [2] is in the first case, in which the retina would carry out a plastic adjustment to the statistics of a whole environment. In that case, adaptation to vertical bars could be seen as mimicking adaptation to the forest environment: responses to any vertical line would be reduced.
On the other hand, adaptation to a particular pattern of vertical bars could represent no more than adaptation of a particular set of stimulated retinal neurons, in which case adaptation would only affect responses to that particular pattern. An experiment seeking adaptation to a more generalized stimulus -a pattern of vertical bars whose location jittered unpredictably -yielded far weaker evidence of pattern specific adaptation.
The second missing piece is that dynamic predictive coding was shown by about half of the retina's ganglion cells, but little is known about which types of cells they were. Different types of ganglion cell specialize in different characteristics of the visual input -some report on brightness, some color, some movement, and so on. Did some types of cell adapt and others not? Which kinds of cells adapt to oriented lines and which to temporal sequences? To answer these questions is surely an important step between the proof of principle attempted here and a concrete understanding of the mechanism's role in vision. Stay tuned.
oncogenic transformation and defective endoreduplication of megakaryocytes and trophoblasts (the latter leading to early embryonic death, which was overcome by breeding techniques).
The discordance in the phenotypes resulting from deletion of either cyclin E or CDK2 led to a major problem. As cyclins are believed to exert their biological activities primarily through cyclin-dependent kinase activation, shouldn't the CDK2 null mice -in which no cyclin Eassociated kinase activity was found -and cyclin E null mice share important phenotypes? If not, does this mean that cyclin E performs physiological functions that are independent of cyclindependent kinase activity? This latter point gained support from a study [8] indicating that cyclin E might initiate S-phase entry via an undefined role in centrosomes, rather than by activating CDK2.
Many of these issues have now been addressed in a report [9] indicating that cyclin E-CDK1 can regulate the G0/G1 and G1/S transitions and is redundant with cyclin E-CDK2. This finding is both reassuring and surprising. Firstly, by demonstrating that CDK1 compensates for the absence of CDK2, this work provides comfort to traditionalists who recoil at the possibility that cyclin E's essential functions are CDK-independent.
But this study [9] also provides evidence for a surprising level of plasticity in cell-cycle regulation. The importance of the cyclin E-CDK1 complex was unmasked by combining the CDK2 null mutation with deletion of the cyclin-dependent kinase inhibitor p27. In fact, two labs independently generated double knockout mice that lacked both CDK2 and p27 [9, 10] . The goal of this work was initially to determine the role of deregulated CDK2 activity in the striking phenotypes of p27 null mice, which include large body size, cell hyperproliferation, and pituitary tumors [11] [12] [13] .
The Kaldis [9] and Barbacid [10] groups both generated double knockout mice to test the prediction that CDK2 ablation would revert the p27 null phenotypes. This was not the case, however, as the double knockout mice were found to display all of the p27 null aberrations. Thus, if unconstrained CDK2 activity does not produce the p27 null phenotypes, could there be another p27-regulated kinase? This possibility was supported by the observation [10] that the proliferation of normal and CDK2 null cells is equally sensitive to inhibition by p27.
However, unlike previous studies in CDK2 null mice, in which cyclin E-associated kinase activity could not be detected, Aleem et al. [9] found significant amounts of cyclin E-associated kinase activity in the double knockout cells, indicating that cyclin E indeed activates another kinase in the absence of CDK2 that is inhibited by p27. They showed cyclin E binding to CDK1 in double knockout and normal cells, and these complexes were catalytically active. Moreover, they found that reducing CDK1 abundance in double knockout cells by RNA interference inhibited S-phase entry after mitogenic stimulation of resting cells, supporting the idea that cyclin E-CDK1 complexes compensate for the lack of cyclin E-CDK2 in these cells. Thus, cyclin E function may require an associated kinase after all, and CDK2's close relative, CDK1, may provide this activity. One caveat of these studies is that the CDK1 knockdown experiments are also likely to inhibit cyclin A activity, and thus fall short of demonstrating an essential cyclin E-CDK1 function as normal cells enter S phase. Nonetheless, the cell-cycle reentry data suggest an intriguing new role for low levels of CDK1 activity beyond its well-described functions in G2/M. These results are also reminiscent of another cell-cycle paradigm: low cyclindependent kinase activity in the early cell-cycle phases followed by high cyclin-dependent kinase activity as the cell cycle progresses.
So Ultimately, we may find that a murine fibroblast can proliferate with only a single cyclindependent kinase left intact. As with the CDK2 null mouse, however, it is likely that such animals would exhibit more subtle defects in cell-cycle regulation, and it may be these very differences that permit the complex proliferative control required by multicellular organisms. Thus, a severely compromised mouse living entirely on CDK1 alone may one day reassure us of our evolutionary advances over yeast -from a cell-cycle point of view at least.
